Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Paul Drew to Microglia

This is a "connection" page, showing publications Paul Drew has written about Microglia.

 
Connection Strength
  
 
 
5.486
  
  1. Kane CJM, Douglas JC, Rafferty T, Johnson JW, Niedzwiedz-Massey VM, Phelan KD, Majewska AK, Drew PD. Ethanol modulation of cerebellar neuroinflammation in a postnatal mouse model of fetal alcohol spectrum disorders. J Neurosci Res. 2021 08; 99(8):1986-2007.
    View in: PubMed
    Score: 0.665
  2. Kane CJM, Drew PD. Neuroinflammatory contribution of microglia and astrocytes in fetal alcohol spectrum disorders. J Neurosci Res. 2021 08; 99(8):1973-1985.
    View in: PubMed
    Score: 0.649
  3. Drew PD, Johnson JW, Douglas JC, Phelan KD, Kane CJ. Pioglitazone blocks ethanol induction of microglial activation and immune responses in the hippocampus, cerebellum, and cerebral cortex in a mouse model of fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2015 Mar; 39(3):445-54.
    View in: PubMed
    Score: 0.440
  4. Kane CJ, Phelan KD, Han L, Smith RR, Xie J, Douglas JC, Drew PD. Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-? agonists. Brain Behav Immun. 2011 Jun; 25 Suppl 1:S137-45.
    View in: PubMed
    Score: 0.335
  5. Xu J, Racke MK, Drew PD. Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis. J Neurochem. 2007 Dec; 103(5):1801-10.
    View in: PubMed
    Score: 0.267
  6. Zhang-Gandhi CX, Drew PD. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. J Neuroimmunol. 2007 Feb; 183(1-2):50-9.
    View in: PubMed
    Score: 0.250
  7. Xu J, Drew PD. 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J Neuroimmunol. 2006 Feb; 171(1-2):135-44.
    View in: PubMed
    Score: 0.232
  8. Xu J, Storer PD, Chavis JA, Racke MK, Drew PD. Agonists for the peroxisome proliferator-activated receptor-alpha and the retinoid X receptor inhibit inflammatory responses of microglia. J Neurosci Res. 2005 Aug 01; 81(3):403-11.
    View in: PubMed
    Score: 0.227
  9. Storer PD, Xu J, Chavis JA, Drew PD. Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. J Neurosci Res. 2005 Apr 01; 80(1):66-74.
    View in: PubMed
    Score: 0.222
  10. Storer PD, Xu J, Chavis J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. J Neuroimmunol. 2005 Apr; 161(1-2):113-22.
    View in: PubMed
    Score: 0.222
  11. Drew PD, Storer PD, Xu J, Chavis JA. Hormone regulation of microglial cell activation: relevance to multiple sclerosis. Brain Res Brain Res Rev. 2005 Apr; 48(2):322-7.
    View in: PubMed
    Score: 0.219
  12. Drew PD, Chavis JA, Bhatt R. Sex steroid regulation of microglial cell activation: relevance to multiple sclerosis. Ann N Y Acad Sci. 2003 Dec; 1007:329-34.
    View in: PubMed
    Score: 0.202
  13. Niedzwiedz-Massey VM, Douglas JC, Rafferty T, Wight PA, Kane CJM, Drew PD. Ethanol modulation of hippocampal neuroinflammation, myelination, and neurodevelopment in a postnatal mouse model of fetal alcohol spectrum disorders. Neurotoxicol Teratol. 2021 Sep-Oct; 87:107015.
    View in: PubMed
    Score: 0.171
  14. Drew PD, Chavis JA. The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. J Neuroimmunol. 2001 Apr 02; 115(1-2):28-35.
    View in: PubMed
    Score: 0.168
  15. Lowery RL, Cealie MY, Lamantia CE, Mendes MS, Drew PD, Majewska AK. Microglia and astrocytes show limited, acute alterations in morphology and protein expression following a single developmental alcohol exposure. J Neurosci Res. 2021 08; 99(8):2008-2025.
    View in: PubMed
    Score: 0.167
  16. Barger SW, Chavis JA, Drew PD. Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J Neurosci Res. 2000 Nov 15; 62(4):503-9.
    View in: PubMed
    Score: 0.164
  17. Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol. 2000 Nov 01; 111(1-2):77-85.
    View in: PubMed
    Score: 0.163
  18. Drew PD, Chavis JA. Inhibition of microglial cell activation by cortisol. Brain Res Bull. 2000 Jul 15; 52(5):391-6.
    View in: PubMed
    Score: 0.160
  19. Chang JY, Chavis JA, Liu LZ, Drew PD. Cholesterol oxides induce programmed cell death in microglial cells. Biochem Biophys Res Commun. 1998 Aug 28; 249(3):817-21.
    View in: PubMed
    Score: 0.141
  20. Kane CJ, Drew PD. Inflammatory responses to alcohol in the CNS: nuclear receptors as potential therapeutics for alcohol-induced neuropathologies. J Leukoc Biol. 2016 11; 100(5):951-959.
    View in: PubMed
    Score: 0.122
  21. Xu J, Wagoner G, Douglas JC, Drew PD. ?-Lapachone ameliorization of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2013 Jan 15; 254(1-2):46-54.
    View in: PubMed
    Score: 0.093
  22. Kielian T, McMahon M, Bearden ED, Baldwin AC, Drew PD, Esen N. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). J Neurochem. 2004 Sep; 90(5):1163-72.
    View in: PubMed
    Score: 0.053
  23. Cealie MY, Douglas JC, Swan HK, Vonkaenel ED, McCall MN, Drew PD, Majewska AK. Developmental Ethanol Exposure Impacts Purkinje Cells but Not Microglia in the Young Adult Cerebellum. Cells. 2024 Feb 23; 13(5).
    View in: PubMed
    Score: 0.051
  24. Kielian T, Drew PD. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. J Neurosci Res. 2003 Feb 01; 71(3):315-25.
    View in: PubMed
    Score: 0.048
  25. Kielian T, Syed MM, Liu S, Phulwani NK, Phillips N, Wagoner G, Drew PD, Esen N. The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses. J Immunol. 2008 Apr 01; 180(7):5004-16.
    View in: PubMed
    Score: 0.017
  26. Lovett-Racke AE, Hussain RZ, Northrop S, Choy J, Rocchini A, Matthes L, Chavis JA, Diab A, Drew PD, Racke MK. Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J Immunol. 2004 May 01; 172(9):5790-8.
    View in: PubMed
    Score: 0.013
  27. Diab A, Hussain RZ, Lovett-Racke AE, Chavis JA, Drew PD, Racke MK. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. J Neuroimmunol. 2004 Mar; 148(1-2):116-26.
    View in: PubMed
    Score: 0.013
  28. Diab A, Deng C, Smith JD, Hussain RZ, Phanavanh B, Lovett-Racke AE, Drew PD, Racke MK. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2002 Mar 01; 168(5):2508-15.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.